AIM2 and colorectal carcinoma: Collectively, these studies provide insights into the anti-tumor activity of AIM2 in colon cancer and CRC, paving the way for further investigation into therapeutic strategies targeting AIM2 in colon cancer and CRC patients (Figure 2).